Assessment of in vitro susceptibility to antimicrobials of rapidly growing mycobacteria by E-test;Sensibilidad a los antimicrobianos de micobacterias de crecimiento rápido mediante el método E-test

Revista Medica de Chile

Volumn 137, Issue 7, 2009, Pages 912-917

  García Agudo, Lidia ^a   García Martos, Pedro ^b   Jesús, Iría ^a   Rodríguez Iglesias, Manuel ^a  

^a HOSPITAL UNIVERSITARIO DE PUERTO REAL   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Anti bacterial agents; Bacterial; Drug resistance; Mycobacteriaceae

Indexed keywords

ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; DRUG EFFECT; FEMALE; HUMAN; ISOLATION AND PURIFICATION; MALE; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MYCOBACTERIUM;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MYCOBACTERIUM; YOUNG ADULT;

EID: 70350028496     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Adékambi T, Drancourt M. Isolation of Mycobacterium septicum from the sputum of a patient suffering from hemoptoic pneumonia. Res Microbiol 2006; 157: 466-70.
2. Adékambi T, Foucault C, La Scola B, Drancourt M. Report of two fatal cases of Mycobacterium mucogenicum central nervous immunocompetent patients. J Clin Microbiol 2006; 44: 873-80.
3. Ergan B, Cöplü L, Alp A, Artvinli M. Mycobacterium smegmatis pneumonia. Respirology 2004; 9: 283-5.
4. Hofling-Lima AL, De Freitas D, Sampaio JL, Leao SC, Contarini P. In vitro activity of fluoroquinolones against Mycobacterium abscessus and Mycobacterium chelonae causing infectious keratitis after LASIK in Brazil. Cornea 2005; 24: 730-4.
5. Lee SA, Raad II, Adachi JA, Han XY. Catheter-related bloodstream infection caused by Mycobacterium brumae. J Clin Microbiol 2004; 42: 5429-31.
6. Oh WS, Ko KS, Song JH, Lee MY, Ryu SY, Heo S et al. Catheter-associated bacteriemia by Mycobacterium senegalense in Korea. BMC Infect Dis 2005; 5: 107-11.
7. De Groote MA, Huitt G. Infections due to rapidly growing mycobacteria. Clin Infect Dis 2006; 42: 1756-63.
8. Sungkanuparph S, Sathapatayavongs B, Pracharktam R. Infections with rapidly growing mycobacteria: report of 20 cases. Int J Infect Dis 2003; 7: 198-205.
9. Uslan DZ, Kowalski TJ, Wengenack NL, Virk A, Wilson JW. Skin and soft tissue infections due to rapidly growing mycobacteria: comparison of clinical features, treatment, and susceptibility. Arch Dermatol 2006; 142: 1287-92.
10. Schinsky MF, Morey RE, Steigerwalt AG, Douglas MP, Wilson RW, Floyd MM et al. Taxonomic variation in the Mycobacterium fortuitum third-biovariant complex: Description of Mycobacterium bonickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium newor-leansense sp. nov., Mycobacterium concordense sp. nov., Mycobacterium brisbanense sp. nov., and recognition of Mycobacterium porcinum from human clinical isolates. Int J Syst Evol Microbiol 2004; 54: 1653-67.
11. Brunello F, Ligozzi M, Cristelli E, Bonora S, Tortoli E, Fontana R. Identification of 54 mycobacterial species by PCR-restriction fragment length polymorphism analysis of the hsp 65 gene. J Clin Microbiol 2001; 39: 2799-806.
12. Yang SC, Hsueh PR, Lai HC, Teng LJ, Huang LM, Chen JM et al. High prevalence of antimicrobial resistance in rapidly growing mycobacteria in Taiwan. Antimicrob Agents Chemother 2003; 47: 1958-62.
13. Hoffner SE, Klintz L, Olsson-Liljequist B, Bolmström A. Evaluation of E-test for rapid susceptibility testing of Mycobacterium chelonae and M fortuitum. J Clin Microbiol 1994; 32: 1846-9.
14. Biehle JR, Cavalieri SJ, Saudoble MA, Getsinger LJ. Evaluation of E-test for susceptibility of rapidly growing mycobacteria J Clin Microbiol 1995; 33: 1760-4.
15. Koontz F. E-test for susceptibility testing of rapid growing mycobacteria. Diagn Microbiol Infect Dis 1994; 19: 183-6.
16. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and other Aerobic Actinomycetes; Approved Standard NC-CLS document M24-A. NCCLS, 940 West Valley Road, Suite 1400, Wayne, PA. 2003.
17. European Committee on Antimicrobial Susceptibility Testing (EUCAST) Steering Committee. Eucast technical note on tigecycline. Clin Microbiol Infect 2006; 12: 1147-9.
18. Fernández-Roblas R, Esteban J, Cabria F, López JC, Jiménez MS, Soriano F. In vitro susceptibilities of rapid growing mycobacteria to telithromycin (HMR 3647) and seven other antimicrobials. Antimicrob Agents Chemother 2000; 44: 181-2.
19. Brown-Elliot BA, Wallace RJ, BLINKHORN R, CRIST CJ, Mann LB. Comparison of in vitro activities of gatifloxacin and ciprofloxacin against four taxa of rapidly growing mycobacteria. Antimicrob Agents Chemother 2002; 46: 3283-5.
20. Ruiz-Aragón J, García-Agudo L, Flores S, Rodríguez MJ, Marín P, García-Martos P. Sensibilidad a los antimicrobia-nos de micobacterias de crecimiento rápido. Rev Esp Quimioter 2007; 20: 429-32.
21. Vemulapalli RK, Cantey JR, Steed LL, Knapp TL, Thielman NM. Emergence of resistance to clarithromycin during treatment of disseminated cutaneous Mycobacterium chelonae infection: case report and literature review. J Infect 2001; 43: 163-8.
22. Wallace RJ Jr, Brown-Elliot BA, Ward SC, Crist CJ, Mann LB, Wilson RW. Activities of linezolid against rapidly growing mycobacteria. Antimicrob Agents Che-mother 2001; 45: 764-7.
23. Wallace RJ Jr., Brown-Elliot BA, Crist CJ, Mann LB, Wilson RW. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria. Antimicrob Agents Chemother 2002; 46: 3164-7.
24. Bosó-Ribelles V, Romá-Sánchez E, Salavert-Lletí M, Hernández-Martí V, Poveda-Andrés JL. La tigeciclina, el primer antibiótico de una nueva clase: las glicilciclinas. Rev Esp Quimioterap 2007; 20: 19-35.